⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Free accountRanking, alerts and Top 10Sign up with GoogleSign in

AXT AXTI

United StatesTechnology · Semiconductor Equipment & MaterialsUSD
4.7AI score
Rank 1,802 of 2,130
better than 14% of companies
79.79USD
▲ 1,879.9% in one year
AXTI MSCI World +22.1%
Average analyst target
91.60 USD (+14.8%)
5 analysts
52-wk low 4.00High 143.16
📈 Chart on TradingView ↗(affiliate link)Analysis of 08/10/2026

What does it do?

AXT Inc designs and manufactures compound semiconductor substrates (gallium arsenide, indium phosphide, and germanium) sold to chipmakers for optical communications, LED lighting, and high-frequency electronics applications.

Key points

from its scores
  • ✓Strong growth10.0
  • ✓Good share-price trend9.8
  • ✓Very solid balance sheet8.3
  • ✕Demanding valuation1.4
  • ✕Little or no dividend1.5

AI analysis

bottom line, main risk, context and news
Bottom line

Hold only for investors with high risk tolerance and a long horizon; the current valuation offers no margin of safety.

AXT shows exceptional revenue growth of 164.8% and very strong momentum (1507.2% in 12 months), but its valuation is extremely demanding (P/E 1994.75, EV/EBITDA 362.48) and its return on equity is minimal (ROE 1.01%), suggesting the market is discounting future growth not yet reflected in earnings.

⚠ Main risk

The extreme valuation (P/E 1994.75, EV/EBITDA 362.48) leaves the stock highly exposed to any disappointment in growth execution, especially if the semiconductor cycle cools or cash conversion does not improve (currently -330.29%).

Context and risks

No recent relevant news. The macro context (rising US rates, strong dollar) does not materially affect AXT Inc: its semiconductor substrate business does not depend on commodities or conflict maritime routes, and its net cash balance sheet shields it from financial tightening.

Is AXT stock cheap or expensive?

at the analysis date
Pricier than its sector

On EV / EBITDA, it trades 1,676% above the Technology median.

MultipleCompanySectorDifference
EV / EBITDA362.520.4+1,676%
Price / book5.86.3−8%
Price / sales41.75.3+690%

Sector: median of the 283 Technology companies analysed. In bold, the multiples used for the comparison.

Valuation score: 1.4 out of 10 (median for Technology: 5.3).

Average analyst target: 91.60 USD, +14.8% versus the price.

A premium can be justified if the company is of higher quality or grows faster than its sector: Quality / Moat 2.1 (sector 6.4), Growth 10.0 (sector 7.5).

Work out its fair value yourself →How much would you have made investing every month? →

Comparing it with its sector does not say whether it is a good buy: this is not investment advice.

🛒 Where to buy AXTICheapest · US (NYSE/Nasdaq) · sample 200.00 € orderCheapest · US (NYSE/Nasdaq) · sample 200.00 € orderAvailable in your country · US (NYSE/Nasdaq) · sample 200.00 € order
By the cost of that order: commission and FX, taxes excluded (public fee schedules). Brokers marked «affiliate» may pay Meridian a commission at no cost to you. This is not investment advice. · Compare all 22 brokers by real cost →

Score by category

0 to 10 · hover overtap each one to see what it measures
Financial healthiGood8.3Technology median: 6.9
Quality / MoatiPoor2.1Technology median: 6.4
ValuationiPoor1.4Technology median: 5.3
GrowthiExcellent10.0Technology median: 7.5
DividendiPoor1.5Technology median: 1.5
MomentumiExcellent9.8Technology median: 6.3
Risk & ContextiPoor2.5Technology median: 4.8
Technology median7 or more 5 to 7 under 5

Key metrics

at the analysis date · compared with the Technology median
P/Ei
1,994.8
Technology: 31.3above
EV / EBITDAi
362.5
Technology: 20.4above
ROEi
1.0%
Technology: 17.0%below
Operating margini
21.9%
Technology: 15.5%above
Net debt / EBITDAi
−23.47
Technology: 0.20net cash
Revenue growthi
+164.8%
Technology: +16.7%above

Valuation

P/E
1,994.8
Forward P/E
35.5
EV / EBITDA
362.5
Price / book
5.8
Price / sales
41.7
PEG
12.09
Market cap
5.2B USD
Enterprise value
4.9B USD

Profitability

ROE
1.0%
ROA
0.3%
ROIC (approx.)
2.7%
Gross margin
32.2%
Operating margin
21.9%
Net margin
3.2%
Free cash flow
−44.4M USD
FCF yield
−0.8%
Cash conversion
−330%

Solvency

Total debt
101.5M USD
Net debt
−315.7M USD
Cash
417.2M USD
EBITDA
13.4M USD
Net debt / EBITDA
−23.47
Debt / equity
10.67
Current ratio
4.76
Quick ratio
3.61

Growth

Revenue growth
+164.8%
EPS (TTM)
0.04 USD
EPS (forward)
2.25 USD

Dividend

Dividend yield
0.0%
Payout
0.0%

Risk and market

Beta
1.86
Analyst consensus
none (5)
Target price
91.60 USD
52-week range
4.00 – 143.16

Compare it with its sector

All 283 in Technology →
See the full ranking with filters →

Keep browsing the ranking

sorted by score, highest first

Frequently asked questions about AXT

Is AXT stock cheap or expensive?

On EV / EBITDA, it trades 1,676% above the Technology median. Valuation score: 1.4 out of 10 (median for Technology: 5.3). Average analyst target: 91.60 USD, +14.8% versus the price. This is not investment advice.

What score does AXT get on MeridIAn Screener?

It scores 4.7 out of 10, rank 1,802 of 2,130 (better than 14% of the companies analysed). Its strongest category is Growth (10.0) and its weakest, Valuation (1.4). Analysis of 08/10/2026.

How much is AXT worth on the stock market?

Its market capitalisation is 5.2B USD and its enterprise value, debt included, is 4.9B USD.

How much debt does AXT have?

It has more cash than debt: net cash of 315.7M USD.

Does AXT pay a dividend?

It pays no dividend, or almost none.

How has AXT stock performed over the last year?

It has risen 1,879.9% over the last year, excluding dividends. Over the last 52 weeks it has traded between 4.00 and 143.16 USD. Past performance does not guarantee future results.

What do analysts think of AXT?

5 analysts cover it; their average recommendation is “none” and their average target is 91.60 USD (+14.8% versus the price). It is an estimate, not market data.